Skip to content
  • Home
  • About Us ▾
    • Our Company
    • Our History
    • Our Team
    • Contact Us
    • Employment Opportunities
  • Technology ▾
    • MyoReGenX™
    • Articles
  • Satellos Logo Satellos Logo Satellos Logo
  • Programs ▾
    • Muscular Dystrophy and Wasting
    • Ageing Muscle
    • Licensing & Co-Development Opportunities
  • Investor Information
  • News
  • Home
  • About Us ▾
    • Our Company
    • Our History
    • Our Team
    • Contact Us
    • Employment Opportunities
  • Technology ▾
    • MyoReGenX™
    • Articles
  • Satellos Logo Satellos Logo Satellos Logo
  • Programs ▾
    • Muscular Dystrophy and Wasting
    • Ageing Muscle
    • Licensing & Co-Development Opportunities
  • Investor Information
  • News
  • Home
  • About Us ▾
    • Our Company
    • Our History
    • Our Team
    • Contact Us
    • Employment Opportunities
  • Technology ▾
    • MyoReGenX™
    • Articles
  • Satellos Logo Satellos Logo Satellos Logo
  • Programs ▾
    • Muscular Dystrophy and Wasting
    • Ageing Muscle
    • Licensing & Co-Development Opportunities
  • Investor Information
  • News

iCo Therapeutics Announces 2020 Year End Financial Results and Resignation of Susan Koppy

ico_admin2021-12-02T16:43:48+00:00April 29th, 2021|2021, Press Releases|
Copyright © 2021 Satellos - All Rights Reserved.
| [email protected] | Follow @satellosbio | |
Page load link
Go to Top